CSPC PHARMACEUTICAL GROUP LIMITED revenue breakdown overview

CSPC PHARMACEUTICAL GROUP LIMITED revenue for the last year amounted to 34.60 B HKD, the most of which — 28.33 B HKD — came from its highest performing source at the moment, Finished Drugs, the year earlier bringing 24.52 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought CSPC PHARMACEUTICAL GROUP LIMITED 30.04 B HKD, and the year before that — 26.14 B HKD.